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Hematopoietic Stem Cells Expressing
the Myeloid Lysozyme Gene Retain
Long-Term, Multilineage Repopulation Potential
sponds to a “blank slate” and that lineage-specific gene
expression programs only become activated as cells
become committed. This view was shaken when it was
found that single cells from pluripotent hematopoietic
cell lines not only express a variety of lineage restricted
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transcription factors but also classical lineage affiliatedBronx, New York 10461
marker genes such as  globin and myeloperoxidase2 Department of Cancer Immunology and AIDS
(Hu et al., 1997). More recently, these findings wereDana Farber Cancer Institute
extended to Lin, c-Kit, Thy1.1lo, Sca-1 bone marrowHarvard Medical School
cells, of which some 20% have long-term repopulationBoston, Massachusetts 02115
(LTR) potential following transplantation into irradiated
recipients (Morrison et al., 1997; Wagers et al., 2002).
As in the multipotent cell lines, most single HSCs ana-Summary
lyzed by PCR expressed at least one of several myeloid
restricted genes tested, such as  globin or myeloper-Single cell PCR studies showed that hematopoietic
oxidase, and often coexpressed two or more of themstem cells (HSCs) express a variety of lineage-affiliated
(Miyamoto et al., 2002). Together, these observationsgenes. However, it remains unclear whether these cells
were interpreted to suggest that HSCs undergo a pro-exhibiting “lineage priming” represent bona fide stem
cess of lineage priming and that differentiation is initi-cells or a subpopulation earmarked for differentiation.
ated when one gene expression program becomes dom-Here we have used a Cre-Lox approach to follow the
inant, closing all other options (Enver and Greaves, 1998;fate of cells expressing a lineage-affiliated marker. We
Miyamoto et al., 2002). The implication is that this hap-
crossed lysozyme Cre mice with yellow fluorescent
pens in bona fide HSCs, that is, in cells with LTR poten-
protein (EYFP) reporter mice and found EYFP gene
tial (Figure 1A). However, approximately 30% of single
expression not only in myelomonocytic cells but also
HSCs expressed no detectable lineage markers (Miya-
in a fraction of HSCs as well as B cells and T cells.
moto et al., 2002), raising the possibility that only the
Transplantation of EYFP HSCs into primary and sec- lineage marker negative cells exhibit LTR potential, while
ondary recipients generated mice in which all hemato- the marker positive cells are earmarked for differentia-
poietic cells were EYFP. In contrast, crosses between tion (Figure 1B).
CD19 Cre and lck Cre mice with reporter mice showed These alternatives can be tested by isolating HSCs
no EYFP expression in HSCs or intermediate progeni- expressing a given lineage restricted marker and de-
tors. Our results demonstrate that lysozyme expres- termining whether they have LTR potential. In one study
sion does not mark myeloid commitment and that long- early hematopoietic progenitors expressing the platelet
term repopulation potential is maintained in primed integrin GpIIb/CD41 were found to have lymphoid lin-
HSCs. eage repopulation potential but no clear LTR activity
(Corbel and Salaun, 2002). In another study, HSCs (Lin,
Introduction Thy-1low, c-Kit, Sca-1) expressing low levels of the
macrophage integrin Mac-1 were found to be devoid of
long-term repopulation potential, although they exhib-HSCs are probably the best-studied class of adult verte-
ited multilineage differentiation potential (Morrison etbrate stem cells, giving rise to more than 10 well-defined
al., 1997). Surprisingly however, Mac-1 is also expressedlineages through a series of intermediate progenitors.
by a subset of HSCs from fetal liver that were shownTransplantation experiments performed during the last
to have self-renewal capacity (Morrison et al., 1995).few years suggest that HSCs can also “trans-differenti-
Markers that are not detectable on the cell surface areate” into a variety of nonhematopoietic cell types (see
more difficult to study since cells cannot easily be sortedfor example Graf, 2002). In spite of these advances little
and tested. However, it is possible to use lineage-spe-is known about how HSCs decide what to become, and
cific promoters to drive reporter genes either directly orwhether their differentiation is initiated predominantly
indirectly by driving Cre recombinase, whose activityby extrinsic factors or by stochastic events (Enver and
leads to the activation of the reporter (see below). CellsGreaves, 1998; Enver et al., 1998; Metcalf, 1998). There
expressing the reporter gene can then be analyzed andis a consensus, however, that lineage-specific transcrip-
isolated using flow cytometry (FACS).tion factors establish and maintain cell fate by regulating
A classical lineage-affiliated marker is lysozyme Mcell type-specific gene expression programs. For a long
(hereafter called “lysozyme”), which is highly expressedtime it was thought that the ground state of HSCs corre-
in myelomonocytic cells. We have generated a mouse
line in which the egfp gene was inserted into the first
*Correspondence: graf@aecom.yu.edu exon of the lysozyme gene by homologous recombina-
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tion, and which exhibits strong labeling in granulocytes06405.
and macrophages but not in cells from other lineages4 Present address: Department of Cell Biology and Histology, Aca-
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1105 AZ Amsterdam, The Netherlands. these mice leads to an increased inflammatory response
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Figure 1. Diagrams Describing the Concepts
and Strategies Used in This Paper
(A and B) Two alternative models of lineage
priming in hematopoietic stem cells. Cells in
each quadrant represent Lin–, Sca-1, c-Kit
cells, with x and y denoting low expression
levels of lineage-affiliated genes. In (A), cells
with long-term repopulating potential (LTR-
HSC) express lineage affiliated genes. In (B),
only HSCs devoid of LTR potential express
lineage affiliated genes.
(C) Strategy outlining the generation of lyso-
zyme ancestry mice.
(D) Tree of hematopoietic differentiation ac-
cording to Weissman (2000) showing the cell
surface markers used to characterize HSCs
and their differentiated progeny. CLP, com-
mon lymphoid progenitor; CMP, common
myeloid progenitor; GMP, granulocyte/mac-
rophage progenitor; and MEP, megakaryo-
cyte/erythrocyte progenitor.
to bacterial infections due to an impaired function of encoding the B cell restricted marker CD19 or the T cell
restricted marker lck failed to detect expression of thegranulocytes and macrophages (Ganz et al., 2003).
Other than that the mice can be maintained as homozy- markers in HSCs. Our results indicate that expression
in HSCs of the myeloid lineage affiliated gene lysozymegote knockouts and show no overt defects in the hema-
topoietic system (unpublished data). In another knockin gene does not abolish their “stemness” and suggest
that lineage priming is selective.line, the cre recombinase gene was inserted into the
first exon of the lysozyme gene. When crossed with a
reporter mouse containing a lox-P site-flanked cassette, Results
excisions were detected by Southern blotting in myelo-
monocytic but essentially not in B or T cells (Clausen Lysozyme Ancestry Mice Show Unexpected EYFP
Labeling of Lymphoid Cellset al., 1999). However, more recent studies showed that
this gene is also expressed in intermediate progenitors To generate animals in which the ancestry of lysozyme
expressing cells can be traced, lysozyme Cre knockin(Miyamoto et al., 2002).
Here we asked whether lysozyme is expressed in HSCs, mice were crossed with ROSA26 EYFP reporter mice.
The resulting cross was compared to a ROSA26 EYFPusing both the lysozyme EGFP and lysozyme Cre knockin
mice. The latter were analyzed following crossing with reporter mouse as a negative control and to a germ line
deleted ROSA26 EYFP mouse as a positive control. TheROSA26 EYFP reporter mice (Soriano, 1999; Srinivas
et al., 2001). In the resulting lysozyme “ancestry” mice latter allows determining the percentage of cells that
express the reporter gene driven by the endogenousindividual cells can be detected that are either express-
ing lysozyme or that have expressed the gene earlier ROSA26 promoter for each lineage. As shown in Figure
2A (a), negative control cells showed no EYFP labeling,during development. Using this in vivo lineage tracing
technique (Jacob and Baltimore, 1999), we show that whereas 55% of blood leukocytes of the lysozyme an-
cestry mouse were labeled (b) compared to 98% of thelysozyme is indeed expressed at low levels in a subset of
HSCs and that these cells exhibit long-term repopulation cells in the positive control (c). The latter mouse showed
essentially 100% labeling of myeloid, B, and T cells (datapotential. In contrast, analyses of lineage ancestry mice
in which Cre expression is driven by either the gene not shown). We then analyzed myeloid cells, B cells,
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Figure 2. FACS Analyses of Lysozyme An-
cestry Mice
(A) Profiles of blood leukocytes from lyso-
zyme ancestry mice as well as from negative
and positive control mice. (a) Lysozyme an-
cestry mouse, showing 54.6% EYFP cells;
(b) ROSA26 EYFP reporter mouse, showing
no labeled cells; (c) ROSA26 EYFP mouse
with a germ line excision of the stop cassette,
showing 98.3% EYFP cells.
(B) FACS profiles of blood leukocytes from a
lysozyme ancestry mouse, showing distribu-
tion of EYFP cells between myeloid, B, and
T cell populations. The upper row of diagrams
represent profiles obtained after staining with
various antibodies; the lower row shows the
corresponding profiles after gating on EYFP
cells. Numbers in brackets indicate percent-
ages of EYFP cells relative to all cells stained
with a given antibody combination, within the
same quadrant.
(C) Histograms of EYFP cell distributions in
various tissues of lysozyme ancestry mouse
#15. Light gray bars, Mac-1 cells; black bars,
B220 cells; hatched bars, CD4 cells, cross
hatched bars, CD8 cells, stippled bars,
CD4/CD8 cells.
(D) Histograms of EYFP cell distributions in
various blood leukocyte lineages of different
lysozyme ancestry mice. Mice #1 to #5 were
six months old; mice #6 to #8 two months.
Gray bars, Mac-1 cells; black bars, B220
cells; white bars, CD4 plus CD8 cells. No
significant differences were seen between
the proportion of EYFP labeled CD4 and
CD8 cells (not shown). Values shown repre-
sent average of three independent measure-
ments. T-shaped bars, standard deviation.
and T cells from the lysozyme ancestry mice (Lysozyme ing indexes of myeloid and lymphoid cells from 25 lyso-
zyme ancestry mice. The labeling index of Mac-1 cellsCre ki/ki-ROSA EYFP ki/ki) for reporter gene expression.
The cell surface antigens used to phenotype the cells was 85.9  4.0%, range 74.0 to 94.1%; B220 cells:
9.3 3.9%, range 4.5 to 17.2%; CD4 cells: 7.9  3.9%,are indicated in Figure 1C within a simplified scheme
of hematopoietic differentiation (Weissman, 2000). To range 2.2 to 18.9%; and CD8 cells: 7.8  3.8%, range
2.4 to 16.9%. These variations were not due to technicaldetermine the proportion of cells that express the EYFP
reporter, the distribution of cells stained with a given problems since similar values were observed for each
of 8 mice in three consecutive measurements (Figureantibody was compared to cells gated for EYFP expres-
sion, stained with the same antibody. This allows de- 2D). These results show that in lysozyme ancestry mice a
subset of lymphoid (and erythroid) cells is EYFP labeled,termining the percentage of EYFP labeled cells in each
lineage. In the animal analyzed in Figure 2B, 91% of the suggesting that lysozyme is not only expressed in my-
eloid cells but also in multipotent progenitors and per-myeloid cells were EYFP labeled but there was also a
significant proportion of B and T cells that were labeled haps stem cells.
(about 17%). To determine whether various blood form-
ing organs also contained EYFP labeled lymphoid cells, A Subset of HSCs Expresses Lysozyme, Leading
to Irreversible EYFP Labeling of Lymphoidwe tested the spleen, bone marrow, and thymus of an-
other mouse. As shown in Figure 2C, this was indeed Precursors in Lysozyme Ancestry Mice
To determine whether HSCs and intermediate progeni-the case, although the lymphoid labeling index was only
about 8% (a slightly higher percentage of EYFP cells tors express lysozyme, we analyzed bone marrow popu-
lations of lysozyme EGFP mice (hereafter called “indica-was observed for Ter119 erythroid cells; data not
shown). To explore the reason for the discrepancy be- tor” mice). As shown in Figure 3A, in the mouse analyzed
about 20% of HSCs were weakly EGFP positive, as wastween the two mice examined, we determined the label-
Immunity
692
Figure 3. Comparison of EGFP/EYFP Labeling Indexes in HSCs and Intermediate Progenitors
(A) Lysozyme indicator mouse (Lysozyme EGFP ki/ki). (B) Lysozyme ancestry mouse (Lysozyme Cre ki/ki x ROSA EYFP ki/ki). See Experimental
Procedures for definitions of HSCs and intermediate progenitors. Gran/Mac, fraction of Gr-1/Mac-1 cells.
the MEP fraction. Lysozyme expression was upregu- explanation is that the synthesis rates of active Cre (a
tetramer) and EGFP differ, causing a delay between thelated in the myeloid pathway, as indicated by the pres-
ence of 39% EYFP cells in the CMP fraction, 64% production of the recombinase and its ability to cause
excisions. As a consequence, short-lived GMPs andin the GMP fraction, and 96% in the myelomonocytic
fraction. In contrast, expression was downregulated in granulocytes show relatively low percentages of EYFP
cells, although they already express lysozyme. This in-the lymphoid pathway, being essentially undetectable
in B and T cell progenitors. FACS analysis of the corre- terpretation is also supported by the relatively low fluo-
rescence intensity of the Gran/Mac cell fraction in Figuresponding fractions from a lysozyme ancestry mouse
(Figure 3B) revealed similarities but also striking differ- 3B, in which recently formed myeloid cells can be seen
in the process of upregulating ROSA2-EYFP. We do notences: In this mouse, about 9% of HSCs were EYFP,
11% of CMPs and GMPs each and 74% of the myelomo- think that the differences in the percentage of EYFP
cells between HSCs on the one hand and MEPs, CLPs,nocytic fraction. In addition, in contrast to the lysozyme
indicator mouse, the proportion of EYFP cells did not pro T and pre T cells on the other, are significant since
they could not be reproduced in a second mouse. To-decrease in the various lymphoid progenitors or in
MEPs, and remained comparable to that seen in HSCs. gether, our observations indicate that lysozyme is ex-
pressed in HSCs and suggest that the EYFP labeled BThis reflects the fact that Cre-mediated deletion of the
stop cassette in HSCs, activating the EYFP reporter, and T lineage cells seen in the lysozyme ancestry mice
arise from a Cre-mediated activation of the EYFP re-leads to the labeling of all progeny derived from these
cells. Compared to the lysozyme indicator mouse, the porter gene in HSCs. Expression of the lysozyme M gene
is not aberrantly induced by the insertion of the cre orancestry mouse had unexpected low labeling indexes
of GMPs, MEPs, and myelomonocytic cells. A possible egfp knockin genes since we have detected Lysozyme
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by RT-PCR in HSCs (Lin, c-Kit, Sca-1, CD34) of a Mice Transplanted with the EYFP Negative Cell
Fraction Show Restoration of EYFP Labelinglysozyme EGFP ki/ mouse (data not shown) and of
a wild-type mouse by cDNA array analyses (Akashi et in HSCs and B Cells
The observations described above suggest that EYFPal., 2002).
and EYFP progenitors are indistinguishable in their ca-
pacity for multilineage differentiation and self-renewal.EYFP Positive Bone Marrow Cells from Lysozyme
This implies that, given enough time, EYFP negativeAncestry Mice Have Long-Term
HSCs from lysozyme ancestry mice should begin to ex-Repopulation Potential
press lysozyme (and thus EYFP) after transplantation.To test whether lysozyme expressing HSCs exhibit both
Alternatively, it is still also formally possible that this islymphoid and long-term repopulation potential, EYFP
not the case, and that the lysozyme expressers repre-bone marrow cells from lysozyme ancestry mice were
sent a distinct and stable subpopulation. For example,transplanted into irradiated recipients. The advantage
an earlier mesodermal precursor expressing lysozymeof this strategy, as opposed to using EGFP cells from
might be responsible for the labeling of HSCs (if it isthe lysozyme indicator mice, is that EYFP cells of the
assumed that Cre expression levels in HSCs are tooancestry mice form a distinct population that can easily
low to cause excision of the stop cassette). In the firstbe sorted (Figure 3B). However, more importantly, they
alternative, transplanted HSCs should eventually be-can be unambiguously traced in the transplanted ani-
come EYFP positive; in the second, they should remainmals due to the irreversible Cre-mediated activation of
EYFP negative, even after prolonged periods of time.the reporter gene. Two experiments were performed,
Therefore, to distinguish between these alternatives wewith similar outcomes.
analyzed mice transplanted with EYFP cells. One mouseIn Experiment 1, bone marrow cells from two lysozyme
from Experiment 1 was sacrificed 2 months after trans-ancestry mice averaging 15% EYFP B cells were stained
plantation (analysis of the second mouse failed becausewith a cocktail of antibodies against lineage markers (all
of a technical problem). As expected, its myeloid cellsconjugated to phycoerythrin) as well as against c-Kit
were highly labeled (80% EYFP), suggesting that most(conjugated to allophycocyanin). Lin, c-Kit cells (con-
or all cells were donor derived. Significant proportionstaining HSCs as well as various intermediate progeni-
of EYFP cells were also found in the B cell and T celltors) were then sorted into EYFP positive and negative
compartments (0.9% and 2.5% B220 cells in bone mar-fractions, yielding essentially pure populations (Figure
row and spleen; 2.0% and 1.1% CD4 and CD8 cells,4A). For each fraction, 104 cells were then injected into
in spleen). Two mice were sacrificed from Experimenttwo sublethally irradiated SCID mice and blood leuko-
2 (they had been transplanted 6 months earlier with 103cytes analyzed over a period of 20 weeks. As can be
HSCs that were 100% EYFP) and analyzed by FACS.seen in Figure 4B, cells from both fractions were capable
While one animal was essentially fully reconstituted withof reconstituting both B and T cells at roughly compara-
donor cells (mouse #E2-2, average 77% EYFP Mac-1ble efficiencies. We next determined the EYFP labeling
cells in three tissues), the other was only partially recon-index in the lymphoid cell populations of mice trans-
stituted (mouse #E2-4, average of 48% EYFP Mac-1planted with EYFP fraction. As illustrated in Figures 5A
and 5B, the percentage of EYFP B and T lymphocytes cells). As shown in Figure 6A for mouse #E2-2, the spleen
EYFP labeling indexes for B220, CD4, and CD8 cellsreached almost 100% after 8 weeks. Two mice were
sacrificed 7 months after transplantation and their cells were 10.8%, 3.6%, and 5.0%, respectively, while the
labeling index for bone marrow HSCs was 6.8% (Figureanalyzed by FACS. In animal #E1-1, more than 95% of
B and T lineage cells in the blood, bone marrow, spleen, 6B). Slightly lower values were obtained for the second
mouse (data not shown).and thymus were EYFP, while mouse #E1-2 showed
slightly lower values. We also analyzed the stem cell The above observations are compatible with the no-
tion that both EYFP and EYFP HSCs have long-termfraction of mouse #E1-1. As shown in Figure 5C, 99.3%
of Lin, Sca-1, c-Kit cells were found to be EYFP repopulation potential and that they express lysozyme
in an oscillating manner. This predicts that in lysozymelabeled. Results obtained with mice transplanted with
the negative fraction will be discussed below. ancestry mice, while the population of EYFP cells is
maintained, there should be a continuous recruitmentIn Experiment 2, Lin, c-Kit, Sca-1 cells were sorted
from bone marrow of a pool of three lysozyme ancestry of novel EYFP cells from the negative fraction. Hence,
assuming that there is no difference in the repopulationmice (averaging 11% EYFP B220 cells) into an EYFP
and an EYFP fraction. Two animals each were injected potential of cells from the two fractions, this should
result in the gradual increase in the percentage of EYFPwith EYFP positive and negative fraction HSCs and ana-
lyzed 6 months after transplantation. Here again, mice labeled cells over time, starting from the original base-
line. However, a comparison between 2- and 6-month-transplanted with the EYFP positive fraction not only
exhibited nearly 100% EYFP positive myeloid cells but old lysozyme ancestry mice showed no significant dif-
ferences (Figure 2D), either because the age differencealso lymphoid cells in the blood, bone marrow, and
spleen. Bone marrow from one of these animals was was too small or because HSCs were largely quiescent.
Therefore, to test whether an age-dependent increaseused to perform a secondary transplantation into three
irradiated SCID mice. These recipients, analyzed 6 weeks can be seen under conditions of transplantation (where
HSCs are induced to proliferate), we injected 2  106later, showed between 98.2% and 100% labeling in their
peripheral blood B and T cell population (B220, CD4, bone marrow cells from a single lysozyme ancestry
mouse (in which 5.5% of the B cells were EYFP labeled)CD8; data not shown). We conclude that EYFP labeled
HSCs from lysozyme ancestry mice have long-term re- into each of five lethally irradiated C57BL/6 mice (Experi-
ment 3). As can be seen from the analysis of the micepopulation potential.
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Figure 4. Isolation of EYFP and EYFP– He-
matopoietic Progenitors from Lysozyme An-
cestry Mice and Their Lymphoid Repopula-
tion Capacity
(A) Profile of Lin- bone marrow cells (c-Kit
antibody staining versus EYFP fluorescence)
and re-analysis of the FACS sorted cells.
Numbers indicate % of cells in a given quad-
rant. (B) Kinetics of lymphoid cell repopula-
tion of mice #E1-1 and E1-2 each trans-
planted with either the EYFP positive or
negative fraction. The bars indicate variations
observed between the two animals.
14 months later (Figure 6C), all animals exhibited an up and T cell lineage ancestry mice, using lines where Cre
is driven by the endogenous CD19 promoter (Rickert etto 6-fold higher B cell labeling index compared to that
al., 1997) or the lck promoter (Lee et al., 2001), respec-of the original donor mouse. The data also show similar
tively. In a set of pilot experiments we analyzed the bloodanimal-to-animal variations as the original ancestry mice
leukocytes of a total of 8 CD19 and 34 lck ancestry mice.(Figure 2D). The observed increase was not due to an
While all of the CD19 mice showed the expected patternupregulation of lysozyme expression within the B cell
(specific EYFP labeling of B cells), the situation with thelineage, since the mouse with the highest proportion of
lck ancestry mice was more complex. Thus, of 34 micelabeled B cells (31.5%, animal #1 in Figure 6C) showed
examined, 29 showed a specific EYFP labeling of thea similar HSC labeling index (36.6%, Figure 6D). The
T cell fraction while 5 showed strong labeling in all lin-T cell labeling index also increased in all five mice, al-
eages. Chris Wilson’s lab, which created the mice, hasthough CD4 cells generally exhibited a higher propor-
made similar observations (see http://depts.washington.tion of labeling than CD8 cells.
edu/immunweb/faculty/wilsonlab-reagent.html). TwoTogether, these experiments show that half a year
CD19 ancestry mice and two lck ancestry mice fromafter transplantation of EYFP progenitors from lyso-
the narrowly expressing group were chosen for morezyme ancestry mice a subset of HSCs had again become
detailed analyses. For CD19 Cre ROSA EYFP no signifi-EYFP labeled. Likewise, in mice transplanted with a mix-
cant numbers of EYFP cells could be found in Mac-1ture of EYFP and EYFP bone marrow cells the propor-
and CD8 cells from blood (Figure 7A) and in CD4,tion of EYFP labeled B cells and HSCs increased dramat-
CD8 cells from thymus (data not shown). EYFP labeledically over the period of a year.
cells could neither be detected in HSCs (Figure 7B) nor
in a fraction containing CLPs, CMPs, GMPs, and MEPs
Analysis of Lymphoid Ancestry Mice Shows Absence (0 EYFP cells in 60,000 Lin, c-Kit, Sca-1 cells from
of CD19 and lck Priming in HSCs mouse #9 and 1 EYFP cell in 131,000 Lin, c-Kit,
To determine whether HSCs not only “preview” myeloid Sca-1 cells from mouse #10). The analysis of the two
lck ancestry mice likewise revealed no significant pro-genes but also lymphoid affiliated genes, we created B
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pletely EYFP negative (Figure 7D), as were CLPs, CMPs,
GMPs, and MEPs (1 EYFP cells in 195,000 Lin, c-Kit,
Sca-1 cells from mouse #1 and 4 EYFP cells in 152,000
Lin, c-Kit, Sca-1 cells from mouse #2). In conclusion,
with the Cre-Lox lineage ancestry approach chosen, we
could not detect HSC lineage priming for either of the
two lymphoid genes examined.
Discussion
Promiscuous Expression of Lysozyme M Extends
the Lineage-Priming Concept to Bona Fide
Hematopoietic Stem Cells
Our data demonstrate that lysozyme M is expressed in
long-term repopulating hematopoietic stem cells, thus
ruling out the possibility that promiscuous expression
of a lineage affiliated marker gene necessarily commits
them to differentiation. Our observations thus support
and extend the “lineage priming” model popularized by
Enver and colleagues. (This model is based on the ob-
servation that multilineage precursors express a combi-
nation of lineage restricted genes before a given gene
expression program becomes dominant during lineage
commitment [Brady et al., 1995; Enver and Greaves,
1998; Hu et al., 1997]). They also support our earlier
findings that showed that lysozyme is expressed in a
subpopulation of CMPs without reducing the capacity
of the expressers to form erythroid/megakaryocytic col-
onies (Miyamoto et al., 2002). Although it is clear that
both lysozyme positive and negative HSCs exhibit long-
term repopulation activity and are capable of reconsti-
tuting secondary recipients, the present study did not
address the question of whether the two populations
differ in quantitative terms. However, we think that lyso-
zyme expressing HSCs (or HSCs that expressed it at
some point) are at least as competent as lysozyme nega-
tive HSCs since they exhibit similar lymphoid repopula-
tion kinetics (Figure 4B and data not shown). In addition,
neither population is strongly dominant, as suggested
by the results of the transplantation experiment with a
mixture of EYFP and EYFP bone marrow cells (Figure
6C). It cannot be excluded that lysozyme M has an as
yet undetected role in HSCs, in which case the observedFigure 5. Analysis of Mice Transplanted with EYFP Positive Hema-
expression might not represent “lineage priming.” How-topoietic Progenitors from a Lysozyme Ancestry Mouse
ever, this seems unlikely since HSCs from lysozyme(A) Profiles of blood leukocytes from mouse #E1-1, 5 months after
defective mice can be transplanted and yield multilin-transplantation with the EYFP positive cell fraction. FACS profiles
are shown before and after gating on EYFP cells. eage progeny in normal proportions.
(B) Kinetics of lymphoid repopulation in mice transplanted with the
EYFP positive cells, showing EYFP cells only. Values shown repre- Possible Explanations of the Observed Animal-to-
sent the average observed for mice #E1-1 and 2 (variations were
Animal Variations in the Lysozyme Ancestry Micebelow 15%). Not all lymphoid cells were EYFP after 4 and 6 weeks
A comparison of individual lysozyme ancestry mice ofbecause SCID mice develop some B220, CD4, and CD8 cells
identical genotype revealed surprisingly large variationsfollowing irradiation (unpublished data).
(C) FACS profiles of Lin– bone marrow cells from mouse #E1-1 trans- in the proportions of EYFP labeled cells in the HSC and
planted with EYFPprogenitors 7 months earlier, showing Sca-1 and B cell compartments (Figure 2D and not shown). One
c-Kit stained cells before and after gating of EYFP cells. Numbers in possibility to explain these variations is the heterogene-
brackets indicate percentage of cells that are EYFP relative to all
ity in the genetic background of the lysozyme ancestrycells in the corresponding quadrant.
mice, although similar variations were seen in C57BL/6
mice transplanted with aliquots of the same bone mar-
row sample from a single lysozyme ancestry mouse. Weportions of EYFP positive B220/Mac-1 cells in the
blood (Figure 7C), spleen, and bone marrow (data not therefore think it is more likely that stochastic events
play a role, assuming that during transplantation theshown). The EYFP labeled CD4/CD8/Mac-1/B220
cells observed in the blood (Figure 7C) might represent bone marrow is reconstituted by a few dominant HSC
clones. As a consequence, animals with high labelingdelta  T cells and/or NK cells. HSCs were again com-
Immunity
696
Figure 6. Analysis of Mice Transplanted with EYFP Negative Hematopoietic Progenitors
(A) FACS profiles of spleen from mouse #E2-2, transplanted 6 months earlier, before and after gating on EYFP cells. Numbers in brackets
indicate percentage of cells that are EYFP relative to all cells in the corresponding quadrant.
(B) Profile showing percentage of EYFP HSCs (Lin–, Sca-1, c-Kit) from mouse #E2-2.
(C) EYFP labeling indexes of peripheral blood leukocytes of five mice transplanted with bone marrow of a lysozyme ancestry mouse 14 months
earlier. Gray bars, Mac-1 cells; black bars, B220 cells; hatched bars, CD4 cells; crosshatched bars, CD8 cells.
(D) Profile showing percentage of EYFP HSCs (Lin–, Sca-1, c-Kit) of mouse #1 (C).
indexes might have been repopulated with a larger pro- been observed for transgenes expressed in muscle fi-
bers (Newlands et al., 1998) and in erythroleukemia cellsportion of EYFP positive clones. The timing of the onset
of lysozyme expression also matters: the earlier EYFP (Feng et al., 1999; Hume, 2000). That no distinct EGFP
population could be seen in HSCs from the lysozymebecomes expressed in the transplanted HSCs the higher
will be the proportion of EYFP labeled progeny observed indicator mice is consistent with the idea that there is
a continuum of cells with different levels of lysozyme.after prolonged time intervals. While there was a good
correlation between the labeling index of HSCs and B In this view, the observed lysozyme expression profile
represents a “snapshot” that becomes arrested in thelineage cells, this was less true for T cells, which in
transplanted animals typically exhibited lower labeling lysozyme ancestry mice. Here, because EYFP is driven
by the strong ROSA26 promoter, expressers constituteindexes. Since EYFP T cells develop normally in the
absence of competing EYFPT cells (Figure 5B) reporter a distinct population. As estimated from a comparison
of the fluorescence intensity of EGFP in myelomonocyticpositive T cells are probably at a disadvantage when
competing with nonexpressers. cells and HSCs from lysozyme indicator mice, HSCs
express less than 100 times lysozyme. It is not known
whether this low level expression (which has also beenImplications for Gene Oscillation Models
The finding that EYFP negative cells become positive described for other lineage marker genes, such as my-
eloperoxidase and  globin (Hu et al., 1997; Miyamotoafter transplantation is compatible with the notion that
HSCs express lysozyme in a oscillating manner, as has et al., 2002), is due to a transcription factor dependent
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Figure 7. Analysis of CD19 and lck Ancestry
Mice
(A) FACS profiles of blood leukocytes from
CD19 ancestry mouse #9 shown before and
after gating on EYFP cells.
(B) Profiles showing percentage of EYFP
HSCs (Lin–, Sca-1, c-Kit) cells from CD19
ancestry mice #9 and #10.
(C) FACS profiles of blood leukocytes from
lck ancestry mouse #1 before and after gating
on EYFP cells.
(D) Profiles showing percentage of EYFP
HSCs (Lin–, Sca-1, c-Kit) cells from lck an-
cestry mice #1 and #2. Numbers in brackets
indicate percentage of cells that are EYFP
relative to all cells in the corresponding
quadrant.
or independent mechanism. If the former would be the of the lineage ancestry approach, which allows de-
tecting not only cells that actually express the Cre re-case, myelomonocytic genes regulated by the same set
porter gene but also all cells that expressed it at anof transcription factors, such as PU.1, C/EBP, AML-1
earlier point and that are therefore irreversibly marked.and Myb (Tenen et al., 1997), should oscillate within one
In addition, the marked cells are amplified through expan-cohort while erythroid restricted genes should oscillate
sion of intermediate and monopotent progenitors, gen-within another. If the latter would be true, their expres-
erating large numbers of reporter positive cells in allsion would be equally distributed between the lysozyme
lineages. However, in spite of the assay’s sensitivity, wepositive and negative fraction. These alternatives are
cannot rule out that HSCs express CD19 and lck atnow testable.
levels too low to excise the stop cassette in the reporter
mouse. It is also possible that the lck transgene in the
Apparent Selectivity of Lineage Priming mouse line used does not fully recapitulate the activity
Can the observed expression of lysozyme in bona fide of the endogenous promoter/enhancer. In spite of these
HSCs be generalized to other myeloid genes? As men- caveats our observations strongly reinforce the notion
tioned in the introduction, the answer is probably no, that CD19 and lck genes are expressed in a highly lin-
since low levels of both GpIIb and Mac-1 seem to mark eage restricted manner. Our results also indicate that
adult HSCs devoid of long-term repopulation potential CD19, B220 cells from adult bone marrow, described
(Corbel and Salaun, 2002; Morrison et al., 1997). Also, to have both B cell and macrophage potential in culture
in striking contrast to the lysozyme gene, lineage priming (Montecino-Rodriguez et al., 2001), do not contribute to
in HSCs could not be observed for the B cell marker the myelomonocytic population in vivo. Finally the data
gene CD19 and for the T cell marker gene lck. While suggest that in unperturbed mice, once progenitors
none of the published work indicated that CD19 or lck have entered the B or T cell differentiation pathway,
is expressed in HSCs, this also seemed to be the case cells do not switch to acquire new identities.
for lysozyme at the outset of our studies (Clausen et al., Although our work is limited to only two lymphoid
genes, it supports and extends earlier findings obtained1999). This can be explained by the exquisite sensitivity
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GTG CTG CCA TGC CTC-3 (CD19 5), 5-GTC TGA AGC ATT CCAby PCR analysis of single HSCs (Miyamoto et al., 2002),
CCG GAA-3 (CD19 3), and 5-CCG GTT ATT CAA CTT GCA CCA-and by cDNA array analysis (Akashi et al., 2002). How-
3 (Cre 3). PCR fragments of 560 bp and 300 bp were indicative ofever, in the latter study a few of the more than 100
wild-type CD19 alleles and the cre knock in, respectively. The Lck-
lymphoid affiliated genes tested were also detected in Cre transgenic mice were genotyped with the cre-specific primers
the HSC fraction. The apparent absence of lymphoid 5-TGA TGA GGT TCG CAA GAA CC-3 and 5-CCA TGA GTG AAC
GAA CCT GG-3, resulting in a 390 bp PCR product. PCR genotypinglineage priming is especially intriguing in view of the fact
of the ROSA26 reporter mouse was done with the following threethat HSCs express, besides myeloid lineage markers, a
primers: 5-AAA GTC GCT CTG AGT TGT TAT-3, 5-GCG AAG AGTvariety of genes that are normally associated with the
TTG TCC TCA ACC-3 and 5-GGA GCG GGA GAA ATG GAT ATG-differentiation of nonhematopoietic cells (Akashi et al.,
3. The sizes of the wild-type and mutant fragments were 500 bp
2002). A similar selective, low level promiscuous gene and 250 bp, respectively. All reactions were performed with 100 ng
expression has been described for thymic epithelial cells tail DNA for 30 cycles each at 30 s denaturation at 94C, 30 s
annealing at 60C, and 60 s elongation at 72C. The products were(Kyewski et al., 2002). Ectopic activation of these genes
analyzed on a 1.5% agarose gel.has recently been ascribed to the transcription factor
AIRE and shown to play an important role in T cell toler-
ance (Anderson et al., 2002). What causes selectivity FACS Analysis of Hematopoietic Cells
Before analysis of samples by flow cytometry, erythrocytes wereof lineage priming in the hematopoietic system? Are
first removed by lysis buffer (155 mMol/L NH4Cl, 10 mMol/L KHCO3,chromatin domains corresponding to a subset of my-
and 0.1 mMol/L EDTA) and cells stained with various antibodies.eloid/nonhematopoietic genes “open for business” while
Phycoerythrin (PE)- or allophycocyanin (APC)-labeled antibodies di-
domains associated with lymphoid genes are closed? rected against B220 (RA3-6B2), CD4 (L3T4), CD3 (145-2C11), CD8
Studies with chicken multipotent myeloid progenitor cell (53-6.7), CD19 (1D3), Gr-1 (RB6-8C5), c-Kit (2B8), Mac-1 (M1/70),
lines suggest that the lysozyme promoter has an open and Ter119 (TER-119) were purchased from PharMingen (San Diego,
CA). Between 10,000 and 50,000 events were collected per samplechromatin configuration, although they do not yet ex-
using a FACSCalibur flow cytometer (Becton Dickinson), and datapress the gene (Kontaraki et al., 2000). A comparison of
analyzed using Cell Quest (Becton Dickinson) and Flow Jo (Santhe chromatin configurations of the regulatory regions
Carlos, CA) software.
of lysozyme, CD19, and lck genes in HSCs might yield
clues as to what initiates the switch from hematopoietic
Sorting of Stem Cells and Intermediate Progenitorsstem cells to lymphoid progenitors.
Analysis of HSCs and intermediate progenitors was essentially per-
formed as described earlier (Akashi et al., 2000). Hematopoietic
Experimental Procedures stem cells (HSCs) were sorted as IL-7R Lin Sca-1hi, c-Kithi; com-
mon myeloid progenitors (CMPs) as IL-7R Lin Sca-1, c-Kit,
Mice CD34, Fc  RII/IIIlo; granulocyte-macrophage progenitors (GMPs)
The indicator lysozyme mice were developed by inserting the egfp as IL-7R Lin Sca-1 c-Kit, CD34, Fc  RII/IIIhi; megakaryocyte-
gene into the first exon of the lysozyme M locus through homologous erythrocyte progenitors (MEPs) as IL-7R Lin Sca-1, c-Kit,
recombination (Faust et al., 2000). CD34, Fc  RII/IIIlo; common lymphoid progenitors (CLPs) as IL7-
They were used as homozygotes (lysozyme EGFP ki/ki). Lysozyme R, Lin Sca-1lo c-Kit; pro-B cells as B220, IgM, CD43; pre-B
ancestry mice were obtained by crossing two mouse lines: Lyso- cells as B220, IgM, CD43; and pro-T cells and pre-T cells were
zyme-Cre mice, in which cre cDNA was inserted via homologous sorted as CD3 CD4 CD8 NK1.1 c-Kit CD25 CD44 and CD3
recombination into the first exon of the lysozyme M gene (Clausen CD4 CD8 NK1.1 c-Kit CD25 CD44, respectively. All progeni-
et al., 1999), and ROSA26 reporter mice, in which a stop cassette tor populations were sorted using a dual laser of 488 nm (Coherent
was inserted into the ROSA26 gene by homologous recombination I 90) and 633 nm (Spectraphysics) with a high-speed cell sorter
(Soriano, 1999). In the particular reporter line used, removal of the (Moflo-MLS, Cytomation, Fort Collins, CO). Cells were reanalyzed
loxP site flanked stop cassette by Cre recombinase activates EYFP using the same machine. To determine the level of autofluorescence
expression (Soriano, 1999; Srinivas et al., 2001). Mice homozygous in the different populations and to obtain the correct settings, the
for both lysozyme Cre and ROSA26 EYFP were used in this study corresponding populations were sorted in parallel from a wild-
(lysozyme Cre ki/ki x ROSA EYFP ki/ki). To obtain CD19 ancestry type mouse.
mice, CD19 Cre mice, generated by insertion of the cre gene up-
stream of the CD19 gene (Rickert et al., 1997), were crossed with
the ROSA26 EYFP reporter line. For the present studies mice hetero- Reconstitution of Irradiated Mice
Experiment 1: Two-month-old SCID mice (C.B-17 scid/scid) werezygous for CD19 Cre and homozygous for ROSA26 EYFP were used
(CD19 Cre ki/ x ROSA EYFP ki/ki). To obtain lck ancestry mice, sublethally irradiated with 300 rad and 2 mice each injected with
either 104 EYFP or 104 EYFP, Lin, c-Kit cells. These cells weretransgenic lck Cre mice (Lee et al., 2001), purchased from Taconic
(Germantown, NY), were crossed with the ROSA26 EYFP reporter obtained from the bone marrow of two lysozyme ancestry mice that
exhibited 16.1% and 13.8% EYFP labeling in the B cell compartment,mice. Double heterozygous mice (lck Cre / x ROSA EYFP ki/)
were used in this study. The ROSA26 EYFP mice were obtained respectively. The levels of donor-derived blood nucleated cells were
monitored at different times thereafter. Two mice transplanted withafter crossing -actin-Cre mice (Lewandoski and Martin, 1997) with
ROSA EYFP reporter mice, using progeny exhibiting a germ line the EYFP fraction were sacrificed after 7 months and cells from
the blood, spleen, thymus, and long bones analyzed by FACS. Ex-deletion of the stop cassette. The genetic background of the lyso-
zyme, CD19, and lck ancestry lines is heterogeneous, consisting of periment 2: Two-month-old SCID were irradiated with 300 rad and
two mice each injected with 103 FACS sorted lin, Sca-1, c-Kitmostly C57Bl background mixed with some 129 background. Mice
were bred and maintained in the Research Animal Facility at Albert cells from a pool of cells from three lysozyme ancestry mice averag-
ing 11.1% EYFP B cells. The postsort analysis showed that theEinstein College of Medicine in accordance with guidelines from
the Institute for Animal Studies. EYFP negative fraction was 100% pure. Mice were sacrificed 6
months after transplantation for FACS analysis and to perform aThe following oligonucleotides were used for PCR genotyping of
the lysozyme-Cre mouse: 5-CTT GGG CTG CCA GAA TTT CTC-3 secondary transplantation with 105 bone marrow cells into three
irradiated SCID mice. The blood of the secondary recipients was(lysozyme 5); 5-TTA CAG TCG GCC AGG CTG AC-3 (lysozyme
3); 5-CGC GCC TGA AGA TAT AGA AGA-3 (Cre 3). PCR fragments analyzed 6 weeks later. Experiment 3: Two-month-old C57BL/6 mice
were lethally irradiated 2with 600 rad prior to intravenous injectionof 350 bp and 470 bp were indicative of the wild-type lysozyme
alleles and cre knockin, respectively. The following oligonucleotides of 2  106 bone marrow cells. The donor cells came from a single
lysozyme ancestry mouse exhibiting 5.5% EYFP cells in the B cellwere used for PCR genotyping of the CD19-Cre mouse: 5-AAT GTT
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compartment. The radiation chimeras were analyzed 14 months Jacob, J., and Baltimore, D. (1999). Modelling T-cell memory by
genetic marking of memory T cells in vivo. Nature 399, 593–597.after transplantation.
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